Event Details
Location
FedEx Institute of Technology
University of Memphis
365 Fogelman Drive
Memphis, TN 38152
Featured Topics
Attendees will gain valuable clinical insights into some of the most significant developments in oncology today, including:
- Precision oncology and early cancer detection
- Emerging cellular therapies and innovative cancer treatments
- The growing role of circulating tumor DNA (ctDNA) in gastrointestinal cancer care
- Surgical management of gastrointestinal malignancies
- Advances in liver-directed therapies
- Nutrition before, during, and after cancer treatment
- Lifestyle medicine and cancer outcomes
Keynote Presentations
Laura Van Metre Baum, MD, MPH
Dana-Farber Cancer Institute | Harvard Medical School
The Rising Challenge of Early-Onset GI Cancers
Kristen K. Ciombor, MD, MSCI
Vanderbilt-Ingram Cancer Center
The Expanding Role of ctDNA in Gastrointestinal Cancer Care
Faculty
The symposium features a distinguished faculty of oncology specialists, including:
- Bashar Abdulkarim, MD
- Aron Chary, MD
- Aleksandar Jankov, MD
- Philip Lammers, MD
- Michael Tomblyn, MD
- Jesse Wright, MD
Special Session
Attendees will also have the opportunity to learn about Tumor Infiltrating Lymphocyte (TIL) therapy during a special lunchtime session presented in collaboration with Iovance.
Why Attend?
The Mid-South Cancer Symposium is designed to connect healthcare professionals with nationally recognized thought leaders while delivering practical, clinically relevant education that can be applied immediately to patient care. Through expert presentations, multidisciplinary perspectives, and discussion of emerging research, attendees will gain valuable insights into the rapidly evolving field of oncology.
National Leaders. Practical Insights. Better Cancer Care.
